XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses:    
Research and development $ 4,425,728 $ 2,819,189
General and administrative 1,457,353 1,451,425
Total operating expenses 5,883,081 4,270,614
Loss from operations (5,883,081) (4,270,614)
Other income:    
Interest income 32,949 232,698
Net loss $ (5,850,132) $ (4,037,916)
Basic and diluted:    
Net loss per common share (in dollars per share) $ (2.47) $ (2.3)
Weighted average shares outstanding (in shares) 2,367,050 1,755,905